Consumer Cyclical
Live Price
Offline$19.22
+0.00% today
1Y Change
+15.69%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 251 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Pandox AB (publ) (PNDXF) is a Consumer Cyclical stock with a market cap of $32.97B and listed on OTC. The stock last traded around $19.22 and up 15.7% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +4.7%, EPS growth of +78.4%, a dividend yield of 2.7%. What stands out right now is revenue +4.7%, EPS +78.4%, free cash flow -1690.9% with operating margin 54.8% and ROIC 3.1%. The dividend matters to the case here, with a current yield around 2.7%. Valuation is more restrained than many high-expectation growth names at P/E 9.0 and price/sales 4.3. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines PNDXF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PNDXF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PNDXF Max Drawdown
-6.30%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PNDXF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$3.3B
-42.1% YoY
FY Net Income
$610.0M
-85.5% YoY
Free Cash Flow
-$479.0M
-145.8% YoY
Revenue Growth
+4.7%
EPS Growth
+78.4%
Gross Margin
56.9%
Net Margin
48.0%
Income statement
SEK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 7.5B | 7.1B | 6.8B | 5.7B | 3.3B |
| Gross Profit | 4.2B | 3.9B | 3.6B | 3.1B | 1.7B |
| Operating Income | 4.0B | 3.7B | 3.3B | 4.0B | 1.2B |
| EBITDA | 6.0B | 4.4B | 1.4B | 4.4B | 2.1B |
| Net Income | 3.1B | 1.7B | -585M | 4.2B | 610M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
SEK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.2B | 1.3B | 769M | 1.6B | 1.6B |
| Total Assets | 111.9B | 80.7B | 73.2B | 75.2B | 66.8B |
| Total Liabilities | 78.0B | 47.0B | 43.5B | 44.3B | 41.4B |
| Shareholder Equity | 33.7B | 33.5B | 29.6B | 30.7B | 25.2B |
| Total Debt | 53.0B | 38.7B | 35.6B | 37.1B | 35.7B |
| Net Debt | 51.9B | 37.4B | 34.9B | 35.5B | 34.1B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
430M
-81.9% YoY
Capital Expenditures
909M
+31.8% YoY
Free Cash Flow
479M
-145.8% YoY
Key ratios
Gross Margin
56.9%
Operating Margin
54.8%
Net Margin
48.0%
ROE
11.0%
Debt / Equity
1.55x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.